Top Story

Triple-drug regimen yields favorable outcomes in drug-resistant TB

March 11, 2020

Q&A: CDC updates latent TB recommendations for first time in 20 years

March 2, 2020
The CDC and National Tuberculosis Controllers Association, or NTCA, has published updated recommendations for latent tuberculosis, or LTBI, in the MMWR for the first…
In the JournalsPerspective

All biologics increase risk for tuberculosis

December 31, 2019
Among patients with rheumatic diseases, treatment with any biologic increases the risk for tuberculosis, both reactivation and new-onset, with an incidence rate among…
Meeting News

Low clinical value in repeat latent tuberculosis tests in patients taking biologics

November 14, 2019
Repeat, routine testing for latent tuberculosis infection among patients receiving biologics is both costly and of low clinical value, according to findings presented at…
More Headlines »
Case Report

Unilateral Pigmented Paravenous Retinochoroidal Atrophy Associated With Presumed Ocular Tuberculosis

Ophthalmic Surgery, Lasers and Imaging Retina, April 2017, Volume 48 Issue 4
This report describes a case of unilateral pigmented paravenous retinochoroidal atrophy (PPRCA) in a patient with…
More »

Xpert MTB/RIF Ultra: Another advance in TB diagnostics

Infectious Disease News, January 2018
David L Cohn, MD
The development of the Xpert MTB/RIF assay has been the most important breakthrough for the diagnosis of tuberculosis…
More »
Meeting News

VIDEO: Index patient in Minnesota MDR-TB outbreak was infectious for 5 years

April 21, 2018
More »
Healio Jobs